Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M74,848Revenue (TTM) $M20,837Net Margin (%)11.7Altman Z-Score3.6
Enterprise Value $M81,955EPS (TTM) $2.3Operating Margin %16.1Piotroski F-Score6
P/E(ttm)30.3Beneish M-Score-2.4Pre-tax Margin (%)14.1Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %11.9Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %-10.5Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow25.3y-y EBITDA Growth Rate %7.1ROA % (ttm)6.8Higher Current Ratio y-yY
Dividend Yield %3.0PEG--ROE % (ttm)16.3Less Shares Outstanding y-yY
Payout Ratio %88.0Shares Outstanding M1,104ROIC % (ttm)14.3Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYJohn Paulson 2016-09-30 Buy 0.04%$76.85 - $83.4
($80.04)
$ 67.80-15%New holding45,800
LLYKen Fisher 2016-09-30 Add0.02%$76.85 - $83.4
($80.04)
$ 67.80-15%Add 5.62%2,096,406
LLYMario Gabelli 2016-09-30 Reduce$76.85 - $83.4
($80.04)
$ 67.80-15%Reduce -0.85%82,050
LLYLeucadia National 2016-06-30 Sold Out -0.04%$72.01 - $78.75
($75.23)
$ 67.80-10%Sold Out0
LLYKen Fisher 2016-06-30 Add0.04%$72.01 - $78.75
($75.23)
$ 67.80-10%Add 13.66%1,984,912
LLYMario Gabelli 2016-06-30 Reduce$72.01 - $78.75
($75.23)
$ 67.80-10%Reduce -1.43%82,750
LLYDodge & Cox 2016-06-30 Reduce$72.01 - $78.75
($75.23)
$ 67.80-10%Reduce -5.96%29,332
LLYVanguard Health Care Fund 2016-03-31 Add0.21%$69.06 - $84.26
($75.82)
$ 67.80-11%Add 5.49%25,959,710
LLYKen Fisher 2016-03-31 Add0.04%$69.06 - $84.26
($75.82)
$ 67.80-11%Add 18.63%1,746,388
LLYLeucadia National 2016-03-31 Buy 0.04%$69.06 - $84.26
($75.82)
$ 67.80-11%New holding3,600
LLYDavid Dreman 2016-03-31 Buy 0.01%$69.06 - $84.26
($75.82)
$ 67.80-11%New holding900
LLYMario Gabelli 2016-03-31 Reduce$69.06 - $84.26
($75.82)
$ 67.80-11%Reduce -0.47%83,950
LLYDodge & Cox 2016-03-31 Reduce$69.06 - $84.26
($75.82)
$ 67.80-11%Reduce -1.27%31,192
LLYVanguard Health Care Fund 2015-12-31 Add0.13%$76.98 - $87.52
($83.01)
$ 67.80-18%Add 3.16%24,609,530
LLYKen Fisher 2015-12-31 Add0.04%$76.98 - $87.52
($82.95)
$ 67.80-18%Add 18.78%1,472,117
LLYDavid Dreman 2015-12-31 Sold Out -0.01%$76.98 - $87.52
($83.01)
$ 67.80-18%Sold Out0
LLYMario Gabelli 2015-12-31 Reduce-0.01%$76.98 - $87.52
($83.01)
$ 67.80-18%Reduce -13.84%84,350
LLYDodge & Cox 2015-12-31 Reduce$76.98 - $87.52
($83.01)
$ 67.80-18%Reduce -0.13%31,592
LLYHOTCHKIS & WILEY 2015-09-30 Reduce-1.13%$78.26 - $89.98
($84.37)
$ 67.80-20%Reduce -99.30%26,900
LLYVanguard Health Care Fund 2015-09-30 Reduce-0.26%$78.26 - $89.98
($84.37)
$ 67.80-20%Reduce -5.99%23,854,960
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Crowe Maria APresident, Mfg. Operations 2016-10-05Sell2,248$81.37-16.68view
TAI JACKSON PDirector 2016-08-15Buy5,773$80.43-15.7view
TAI JACKSON PDirector 2016-08-12Buy2,560$80.42-15.69view
LILLY ENDOWMENT INC10% Owner 2016-07-29Sell205,000$82.94-18.25view
LILLY ENDOWMENT INC10% Owner 2016-07-28Sell240,000$82.87-18.19view
Zakrowski Donald AChief Accounting Officer 2016-07-28Sell1,213$83.16-18.47view
LILLY ENDOWMENT INC10% Owner 2016-07-12Sell210,000$79.54-14.76view
LILLY ENDOWMENT INC10% Owner 2016-07-07Sell225,000$79.14-14.33view
LILLY ENDOWMENT INC10% Owner 2016-06-30Sell215,000$78.46-13.59view
LILLY ENDOWMENT INC10% Owner 2016-06-29Sell220,000$77.86-12.92view

Press Releases about LLY :

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
52-Week Company Lows Nov 25 2016 
Novo Nordisk Is Being Ignored Oct 06 2016 
Sanofi Sues Merck Over Patent Infringement Sep 20 2016 
Eli Lilly's Future Is Changing Aug 30 2016 
Pharmaceuticals are the New Bonds Aug 30 2016 
Most Bought and Sold Stocks by Hedge Funds May 22 2016 
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market May 22 2016 
Sarah Ketterer Adds to Stake in Eli Lilly May 16 2016 
Manning & Napier Sells Chunks of Stakes in GE, Eli Lilly, Merck Mar 29 2016 
Sanofi's New Products Will Fuel Sales Mar 13 2016 

More From Other Websites
Lilly: Jardiance Label to Add Cardiovascular Indication Dec 06 2016
Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell Dec 05 2016
Top Research Reports for Amazon, Ford & Dow Chemical Dec 05 2016
Why Did the S&P 500 Post Moderate Gains on December 2? Dec 05 2016
4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential Dec 05 2016
8:05 am Eli Lilly confirms FDA approval for a new indication for Jardiance tablets to reduce the... Dec 05 2016
U.S. FDA approves Jardiance® (empagliflozin) tablets to reduce the risk of cardiovascular death in... Dec 05 2016
[$$] Prevention of Alzheimer's is the way forward Dec 04 2016
Lilly Could Pocket $1.7 Billion In Fresh Diabetes Drug Sales In 2025 Dec 02 2016
Lilly Spikes on FDA Jardiance Approval (LLY) Dec 02 2016
FDA lets Lilly cite Jardiance heart data, shares jump Dec 02 2016
Lilly's diabetes drug Jardiance cuts risk of cardiovascular death: FDA Dec 02 2016
FDA: Eli Lilly drug reduces cardiovascular death Dec 02 2016
Lilly Confirms Date and Conference Call for 2017 Financial Guidance Announcement Dec 02 2016
Bringing foreign drugs into the US market is a dangerous ... Dec 01 2016
Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential Dec 01 2016
Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop Nov 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)